US Stock MarketDetailed Quotes

CLYM Climb Bio

Watchlist

1.480
+0.090+6.47%

Close Feb 26 15:59 ET

1.490
+0.010+0.68%

Post 16:04 ET

99.60MMarket Cap-0.87P/E (TTM)

Climb Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Climb Bio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2023/Q1	0.000 / 0.000	--
--	2022/Q4	0.000 / 0.000	--
--	2022/Q3	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2023/Q10.000 / 0.000--

--2022/Q40.000 / 0.000--

--2022/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Climb Bio Earnings Reports

Climb Bio | 8-K: Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 12, 2024 16:42 ET

Climb Bio | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 16:03 ET

Eliem Therapeutics | 8-K: Eliem Therapeutics Reports Second Quarter Financial Results

Aug 14, 2024 06:16 ET

Eliem Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14, 2024 06:11 ET